Rede D'Or São Luiz Past Earnings Performance
Past criteria checks 4/6
Rede D'Or São Luiz has been growing earnings at an average annual rate of 11.4%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 27.9% per year. Rede D'Or São Luiz's return on equity is 8.9%, and it has net margins of 4.4%.
Key information
11.4%
Earnings growth rate
4.9%
EPS growth rate
| Healthcare Industry Growth | 11.6% |
| Revenue growth rate | 27.9% |
| Return on equity | 8.9% |
| Net Margin | 4.4% |
| Next Earnings Update | 06 May 2024 |
Recent past performance updates
Recent updates
Is Now The Time To Look At Buying Rede D'Or São Luiz S.A. (BVMF:RDOR3)?
Apr 18
Earnings Tell The Story For Rede D'Or São Luiz S.A. (BVMF:RDOR3)
Feb 05Is It Time To Consider Buying Rede D'Or São Luiz S.A. (BVMF:RDOR3)?
Jan 15Should You Investigate Rede D'Or São Luiz S.A. (BVMF:RDOR3) At R$23.30?
Oct 17Rede D'Or São Luiz S.A. (BVMF:RDOR3) Analysts Just Trimmed Their Revenue Forecasts By 11%
Jan 27Rede D'Or São Luiz (BVMF:RDOR3) May Have Issues Allocating Its Capital
Sep 09Results: Rede D'Or São Luiz S.A. Beat Earnings Expectations And Analysts Now Have New Forecasts
Aug 19Rede D'Or São Luiz's (BVMF:RDOR3) Returns On Capital Not Reflecting Well On The Business
Jun 09Rede D'Or São Luiz (BVMF:RDOR3) Is Reinvesting At Lower Rates Of Return
Mar 10There Are Reasons To Feel Uneasy About Rede D'Or São Luiz's (BVMF:RDOR3) Returns On Capital
Dec 10Rede D'Or São Luiz S.A.'s (BVMF:RDOR3) P/E Still Appears To Be Reasonable
Nov 19Rede D'Or São Luiz's (BVMF:RDOR3) Problems Go Beyond Weak Profit
Mar 10Revenue & Expenses BreakdownBeta
How Rede D'Or São Luiz makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 46,509 | 2,041 | 1,660 | 0 |
| 30 Sep 23 | 40,761 | 1,719 | 16,290 | 0 |
| 30 Jun 23 | 34,809 | 1,341 | 11,094 | 0 |
| 31 Mar 23 | 28,929 | 1,272 | 6,130 | 0 |
| 31 Dec 22 | 22,987 | 1,195 | 1,032 | 0 |
| 30 Sep 22 | 22,371 | 1,332 | 1,009 | 0 |
| 30 Jun 22 | 21,616 | 1,307 | 985 | 0 |
| 31 Mar 22 | 21,035 | 1,413 | 1,001 | 0 |
| 31 Dec 21 | 20,382 | 1,575 | 962 | 0 |
| 30 Sep 21 | 19,415 | 1,447 | 850 | 0 |
| 30 Jun 21 | 17,914 | 1,434 | 700 | 0 |
| 31 Mar 21 | 15,450 | 690 | 826 | 0 |
| 31 Dec 20 | 14,029 | 428 | 764 | 0 |
| 30 Sep 20 | 13,289 | 428 | 756 | 0 |
| 30 Jun 20 | 12,927 | 355 | 799 | 0 |
| 31 Mar 20 | 13,586 | 1,021 | 515 | 0 |
| 31 Dec 19 | 13,320 | 1,167 | 498 | 0 |
| 30 Sep 19 | 12,780 | 1,170 | 503 | 0 |
| 30 Jun 19 | 12,192 | 1,248 | 489 | 0 |
| 31 Mar 19 | 11,515 | 1,220 | 487 | 0 |
| 31 Dec 18 | 10,915 | 1,170 | 460 | 0 |
| 30 Sep 18 | 10,444 | 1,051 | 448 | 0 |
| 30 Jun 18 | 10,065 | 1,018 | 425 | 0 |
| 31 Mar 18 | 9,685 | 955 | 427 | 0 |
| 31 Dec 17 | 9,417 | 954 | 397 | 0 |
| 30 Sep 17 | 9,005 | 892 | 444 | 0 |
| 30 Jun 17 | 8,599 | 780 | 435 | 0 |
| 31 Mar 17 | 8,302 | 819 | 404 | 0 |
| 31 Dec 16 | 7,912 | 802 | 404 | 0 |
| 30 Sep 16 | 7,628 | 927 | 337 | 0 |
| 30 Jun 16 | 7,299 | 934 | 303 | 0 |
| 31 Mar 16 | 6,886 | 822 | 301 | 0 |
| 31 Dec 15 | 6,452 | 725 | 289 | 0 |
| 30 Sep 15 | 6,063 | 612 | 339 | 0 |
| 30 Jun 15 | 5,621 | 501 | 336 | 0 |
| 31 Mar 15 | 5,225 | 389 | 317 | 0 |
| 31 Dec 14 | 4,992 | 320 | 315 | 0 |
| 31 Dec 13 | 4,128 | 208 | 254 | 0 |
Quality Earnings: RDOR3 has high quality earnings.
Growing Profit Margin: RDOR3's current net profit margins (4.4%) are lower than last year (5.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RDOR3's earnings have grown by 11.4% per year over the past 5 years.
Accelerating Growth: RDOR3's earnings growth over the past year (70.8%) exceeds its 5-year average (11.4% per year).
Earnings vs Industry: RDOR3 earnings growth over the past year (70.8%) exceeded the Healthcare industry 38.6%.
Return on Equity
High ROE: RDOR3's Return on Equity (8.9%) is considered low.